Should C282Y homozygotes with mild iron overload be treated? (Englisch)
- Neue Suche nach: Zoller, H.
- Neue Suche nach: Finkenstedt, A.
- Neue Suche nach: Zoller, H.
- Neue Suche nach: Finkenstedt, A.
In:
JOURNAL OF HEPATOLOGY
;
62
, 3
;
510-511
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Should C282Y homozygotes with mild iron overload be treated?
-
Beteiligte:Zoller, H. ( Autor:in ) / Finkenstedt, A. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 62, 3 ; 510-511
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:2 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 62, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 503
-
From the Editor’s Desk… March 2015| 2015
- 505
-
Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B?Petersen, J. et al. | 2015
- 508
-
Prognostic value of skin perfusion alterations in cirrhotic patients with septic shockFernández, J. et al. | 2015
- 510
-
Should C282Y homozygotes with mild iron overload be treated?Zoller, H. / Finkenstedt, A. et al. | 2015
- 512
-
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionHuang, C. F. / Dai, C. Y. / Yeh, M. L. / Huang, C. I. / Tai, C. M. / Hsieh, M. H. / Liang, P. C. / Lin, Y. H. / Hsieh, M. Y. / Yang, H. L. et al. | 2015
- 519
-
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort studyHsu, Y. H. / Muo, C. H. / Liu, C. Y. / Tsai, W. C. / Hsu, C. C. / Sung, F. C. / Kao, C. H. et al. | 2015
- 526
-
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre studyYuen, M. F. / Ahn, S. H. / Lee, K. S. / Um, S. H. / Cho, M. / Yoon, S. K. / Lee, J. W. / Park, N. H. / Kweon, Y. O. / Sohn, J. H. et al. | 2015
- 533
-
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionAgarwal, K. / Fung, S. K. / Nguyen, T. T. / Cheng, W. / Sicard, E. / Ryder, S. D. / Flaherty, J. F. / Lawson, E. / Zhao, S. / Subramanian, G. M. et al. | 2015
- 541
-
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entryLin, L. T. / Chung, C. Y. / Hsu, W. C. / Chang, S. P. / Hung, T. C. / Shields, J. / Russell, R. S. / Lin, C. C. / Li, C. F. / Yen, M. H. et al. | 2015
- 549
-
Exploration of skin perfusion in cirrhotic patients with septic shockGalbois, A. / Bigé, N. k. / Pichereau, C. / Boëlle, P. Y. / Baudel, J. L. / Bourcier, S. / Maury, E. / Guidet, B. / Ait-Oufella, H. et al. | 2015
- 556
-
Microsteatosis may not interact with macrosteatosis in living donor liver transplantationHan, S. / Ha, S. Y. / Park, C. K. / Joh, J. W. / Kwon, C. H. / Kwon, G. Y. / Kim, G. / Gwak, M. S. / Jeong, W. K. / Ko, J. S. et al. | 2015
- 563
-
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injuryLiu, Y. / Ji, H. / Zhang, Y. / Shen, X. / Gao, F. / He, X. / Li, G. A. / Busuttil, R. W. / Kuchroo, V. K. / Kupiec-Weglinski, J. W. et al. | 2015
- 573
-
Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulationMandili, G. / Alchera, E. / Merlin, S. / Imarisio, C. / Chandrashekar, B. R. / Riganti, C. / Bianchi, A. / Novelli, F. / Follenzi, A. / Carini, R. et al. | 2015
- 581
-
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytesBaxter, M. / Withey, S. / Harrison, S. / Segeritz, C. P. / Zhang, F. / Atkinson-Dell, R. / Rowe, C. / Gerrard, D. T. / Sison-Young, R. / Jenkins, R. et al. | 2015
- 590
-
Role for the endoplasmic reticulum stress sensor IRE1α in liver regenerative responsesLiu, Y. / Shao, M. / Wu, Y. / Yan, C. / Jiang, S. / Liu, J. / Dai, J. / Yang, L. / Li, J. / Jia, W. et al. | 2015
- 599
-
Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamineHealy, M. E. / Chow, J. D. / Byrne, F. L. / Breen, D. S. / Leitinger, N. / Li, C. / Lackner, C. / Caldwell, S. H. / Hoehn, K. L. et al. | 2015
- 607
-
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinomaYeung, O. W. / Lo, C. M. / Ling, C. C. / Qi, X. / Geng, W. / Li, C. X. / Ng, K. T. / Forbes, S. J. / Guan, X. Y. / Poon, R. T. et al. | 2015
- 617
-
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre studyVitale, A. / Burra, P. / Frigo, A. C. / Trevisani, F. / Farinati, F. / Spolverato, G. / Volk, M. / Giannini, E. G. / Ciccarese, F. / Piscaglia, F. et al. | 2015
- 625
-
Inhibition of fibronectin deposition improves experimental liver fibrosisAltrock, E. / Sens, C. / Wuerfel, C. / Vasel, M. / Kawelke, N. / Dooley, S. / Sottile, J. / Nakchbandi, I. A. et al. | 2015
- 634
-
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in miceMeier, R. P. / Mahou, R. / Morel, P. / Meyer, J. / Montanari, E. / Muller, Y. D. / Christofilopoulos, P. / Wandrey, C. / Gonelle-Gispert, C. / Bühler, L. H. et al. | 2015
- 642
-
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitisHartl, J. / Ehlken, H. / Weiler-Normann, C. / Sebode, M. / Kreuels, B. / Pannicke, N. / Zenouzi, R. / Glaubke, C. / Lohse, A. W. / Schramm, C. et al. | 2015
- 647
-
Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagyGuo, R. / Xu, X. / Babcock, S. A. / Zhang, Y. / Ren, J. et al. | 2015
- 657
-
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2Zhou, Y. / Llauradó, G. / Orešič, M. / Hyötyläinen, T. / Orho-Melander, M. / Yki-Järvinen, H. et al. | 2015
- 664
-
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosisde Tayrac, M. / Roth, M. P. / Jouanolle, A. M. / Coppin, H. l. / le Gac, G. r. / Piperno, A. / Férec, C. / Pelucchi, S. / Scotet, V. / Bardou-Jacquet, E. et al. | 2015
- 673
-
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver diseaseMartínez-Uña, M. / Varela-Rey, M. / Mestre, D. / Fernández-Ares, L. / Fresnedo, O. / Fernandez-Ramos, D. / Juan, V. G. / Martin-Guerrero, I. / García-Orad, A. / Luka, Z. et al. | 2015
- 682
-
Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosisBardou-Jacquet, E. / Morcet, J. / Manet, G. / Lainé, F. / Perrin, M. l. / Jouanolle, A. M. / Guyader, D. / Moirand, R. / Viel, J. F. / Deugnier, Y. et al. | 2015
- 690
-
New imaging techniques for liver diseasesVan Beers, B. E. / Daire, J. L. / Garteiser, P. et al. | 2015
- 701
-
Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 updateMiro, J. M. / Stock, P. / Teicher, E. / Duclos-Vallée, J. C. / Terrault, N. / Rimola, A. et al. | 2015
- 712
-
Bioinformatics and database resources in hepatologyTeufel, A. et al. | 2015
- 720
-
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseasePawlak, M. / Lefebvre, P. / Staels, B. et al. | 2015
- 734
-
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyriasSchneider-Yin, X. / van Tuyll van Serooskerken, A. M. / Siegesmund, M. / Went, P. / Barman-Aksözen, J. / Bladergroen, R. S. / Komminoth, P. / Cloots, R. H. / Winnepenninckx, V. r. / zur Hausen, A. et al. | 2015
- 739
-
Reply to: “The rescue of DCD rodent livers grafts: Is there HOPE?”Schlegel, A. / Dutkowski, P. / Clavien, P. A. et al. | 2015
- 739
-
The rescue of DCD rodent livers grafts: Is there HOPE?Kopp, W. H. / Wijermars, L. G. / Ringers, J. / Braat, A. E. et al. | 2015
- 741
-
A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to beWong, F. / O’Leary, J. G. / Reddy, K. R. / Kamath, P. S. / Garcia-Tsao, G. / Maliakkal, B. / Subramanian, R. / Thacker, L. / Bajaj, J. et al. | 2015
- 743
-
Reply to: “A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to be”Fagundes, C. / Barreto, R. / Rodríguez, E. / Graupera, I. / Poch, E. / Solà, E. / Fernández, J. / Ginès, P. et al. | 2015
- 746
-
Interaction between infection and hepatic encephalopathyMerli, M. / Riggio, O. et al. | 2015
- 747
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCTMetussin, A. / Patanwala, I. / Cross, T. J. et al. | 2015
- 748
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: A randomized controlled trialPang, Q. / Liu, C. / Zhang, J. Y. / Xu, X. S. et al. | 2015
- 750
-
Target patients for partial hepatectomy and relationship between PLT and prognosis in BCLC B HCCLei, Y. / Yee, L. W. / Ping, Z. W. et al. | 2015
- 751
-
Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?Carrascosa, M. F. / Salcines-Caviedes, J. R. / Lucena, M. I. / Andrade, R. J. et al. | 2015
- ix
-
Contents| 2015
-
EASL Monothematic Conference, Autoimmune Hepatitis. London, United Kingdom, 2015| 2015
-
Join EASL, Take an active role in the most forward thinking and dynamic Hepatology community worldwide| 2015
-
The 2015 International Liver CongressTM. Vienna, 50th anniversary| 2015
-
EASL Special Conference, Addressing End-Stage Liver Disease, a Multifaceted Challenge. Glasgow, United Kingdom, 2015| 2015
-
EASL Monothematic Conference, Liver Disease in Resource Limited Settings. Bucharest, Romania, 2015| 2015
-
EASL Clinical School of Hepatology Course 25: Management of Critically Ill Cirrhotic Patient. Barcelona, Spain, 2015| 2015
-
Editorial Board| 2015